FDA News

FDA Grants Emergency Use Authorization for Updated Novavax COVID-19 Vaccine
September 03, 2024

The updated COVID-19 vaccine targets the currently circulating Omicron variant JN.1 strain of SARS-CoV-2.

FDA Clears Tubeless Automated Insulin-Delivery System for Adults with Type 2 Diabetes
August 27, 2024

The Omnipod 5 is now the first automated insulin delivery system available for both T1D and T2D in the US.

FDA Grants Approval, EUA for Updated mRNA COVID-19 Vaccines
August 22, 2024

The updated COVID-19 vaccines will include a monovalent component corresponding to KP.2, a strain of the Omicron variant of SARS-CoV-2.

FDA Approves Neffy as First Nasal Spray for Allergic Reactions: Daily Dose
August 20, 2024

Your daily dose of the clinical news you may have missed.

First At-Home, OTC Syphilis Test Granted Marketing Authorization by FDA
August 19, 2024

The First to Know Syphilis Test detects a current or past infection, regardless of successful treatment, in 15 minutes using a drop of blood.

PTSD Treatment: Brexpiprazole plus Sertraline May be First New Option for Patients in 2 Decades
August 15, 2024

The FDA recently accepted the sNDA for brexpiprazole in combination with sertraline and set a PDUFA target action date for February 2025.

Novel Blood Test for CRC Screening Receives FDA Approval: Daily Dose
August 15, 2024

Your daily dose of the clinical news you may have missed.

FDA Approves First Intranasal Epinephrine for Emergency Treatment of Allergic Reactions
August 09, 2024

neffy (epinephrine nasal spray) is the first alternative to epinephrine administered by autoinjector or syringe and is comparable in efficacy to the gold standard.

Roflumilast Cream 0.15% Approved for Treatment of Atopic Dermatitis in Adults, Children: Daily Dose
August 08, 2024

Your daily dose of the clinical news you may have missed.

FDA Approves First Blood Test for Primary Screening of Colorectal Cancer
August 07, 2024

The Shield blood test is approved for primary CRC screening in adults 45 years and older at average risk for the disease.